Veterinary News and Research RSS Feed - Veterinary News and Research

FDA requests $5.1 billion budget for FY 2017 to protect and promote public health

FDA requests $5.1 billion budget for FY 2017 to protect and promote public health

The U.S. Food and Drug Administration is requesting a total budget of $5.1 billion to protect and promote the public health as part of the President's fiscal year (FY) 2017 budget – an eight percent increase over the enacted budget for FY 2016. [More]
New technique allows better understanding of cellular stress reaction

New technique allows better understanding of cellular stress reaction

Stress in the body's cells is both the cause and consequence of inflammatory diseases or cancer. The cells react to stress to protect themselves. Researchers at the University of Zurich have now developed a new technique that allows studying a fundamental response to stress in much more detail than previously possible: the ADP-ribosylation of chromatin. [More]
Cantel Medical to buy Sterility Assurance Monitoring Products division of NAMSA for $13.5 million

Cantel Medical to buy Sterility Assurance Monitoring Products division of NAMSA for $13.5 million

CANTEL MEDICAL CORP., has entered into a definitive agreement with North American Science Associates, Inc. to acquire NAMSA's Sterility Assurance Monitoring Products division for $13.5 million in cash consideration. For the year ending December 31, 2015 this business had adjusted sales of $5.7 million. [More]
'Housekeeping' gene may have a link to male infertility

'Housekeeping' gene may have a link to male infertility

Researchers at Iowa State University have found evidence that a "housekeeping" gene present in every cell of the body may have a link to male infertility. [More]
Zepatier receives FDA approval for treatment of chronic HCV genotypes 1 and 4 infections

Zepatier receives FDA approval for treatment of chronic HCV genotypes 1 and 4 infections

The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. [More]
Halaven (eribulin mesylate) approved for treatment of liposarcoma

Halaven (eribulin mesylate) approved for treatment of liposarcoma

The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug. [More]
New prognostic biomarker may help determine risk of prostate cancer-related death

New prognostic biomarker may help determine risk of prostate cancer-related death

Researchers at the University of Copenhagen have identified a new prognostic biomarker: the neuropeptide pro-NPY, which may help determine the risk of dying from prostate cancer. This particular type of protein is very specific to prostate cancer cells and could help identify whether newly diagnosed patients require radical prostatectomy surgery or if it is safe to delay surgery. [More]
FDA issues draft guidance to address cybersecurity vulnerabilities in medical devices

FDA issues draft guidance to address cybersecurity vulnerabilities in medical devices

The U.S. Food and Drug Administration today issued a draft guidance outlining important steps medical device manufacturers should take to continually address cybersecurity risks to keep patients safe and better protect the public health. [More]

Henry Schein signs agreement to acquire RxWorks

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today an agreement to acquire RxWorks, Inc., a provider of veterinary practice management software primarily to customers in Australia, New Zealand, the UK and the Netherlands, and other countries around the world. [More]
Researcher seeks to identify probiotic mixes to treat Clostridium difficile infections

Researcher seeks to identify probiotic mixes to treat Clostridium difficile infections

Antibiotics that fight infection can adversely affect the digestive tract and give destructive bacteria a chance to flourish, said assistant professor of veterinary and biomedical sciences Joy Scaria of South Dakota State University. His research seeks to identify probiotic mixes to treat intestinal infections, such as Clostridium difficile. [More]
Novel therapy may help in diagnosing, treating heart disease in humans

Novel therapy may help in diagnosing, treating heart disease in humans

A novel therapy tested by University of Guelph scientists for treating a fatal heart disorder in dogs might ultimately help in diagnosing and treating heart disease in humans. [More]
Integra Omnigraft Dermal Regeneration Matrix approved to treat certain diabetic foot ulcers

Integra Omnigraft Dermal Regeneration Matrix approved to treat certain diabetic foot ulcers

The U.S. Food and Drug Administration today approved a new indication for the Integra Omnigraft Dermal Regeneration Matrix (Omnigraft) to treat certain diabetic foot ulcers. The matrix device, which is made of silicone, cow collagen, and shark cartilage, is placed over the ulcer and provides an environment for new skin and tissue to regenerate and heal the wound. [More]
“Anemia and Hemoglobin Testing” guide published by EKF Diagnostics

“Anemia and Hemoglobin Testing” guide published by EKF Diagnostics

EKF Diagnostics, the global in vitro diagnostics company, announces the publication of its new guide, “Anemia and hemoglobin testing” . [More]
U.S. Marshals seize nearly 90,000 bottles of dietary supplements containing kratom

U.S. Marshals seize nearly 90,000 bottles of dietary supplements containing kratom

The U.S. Food and Drug Administration announced today that U.S. Marshals, at the agency's request, seized nearly 90,000 bottles of dietary supplements labeled as containing kratom. The product, manufactured for and held by Dordoniz Natural Products LLC, located in South Beloit, Illinois, is marketed under the brand name RelaKzpro and worth more than $400,000. [More]
Nottingham researchers explore viruses that can destroy food poisoning bugs in the gut

Nottingham researchers explore viruses that can destroy food poisoning bugs in the gut

Viruses that can seek and destroy food poisoning bugs in the gut are being investigated by researchers at The University of Nottingham, thanks to a prestigious new grant. [More]
FDA issues two final orders to strengthen requirements for transvaginal surgical mesh safety

FDA issues two final orders to strengthen requirements for transvaginal surgical mesh safety

The U.S. Food and Drug Administration today issued two final orders to manufacturers and the public to strengthen the data requirements for surgical mesh to repair pelvic organ prolapse (POP) transvaginally, or through the vagina. [More]
Sugary Western diet may increase risk of breast cancer and metastasis to the lungs

Sugary Western diet may increase risk of breast cancer and metastasis to the lungs

The high amounts of dietary sugar in the typical Western diet may increase the risk of breast cancer and metastasis to the lungs, according to a study at The University of Texas MD Anderson Cancer Center. [More]
Newly discovered molecular mechanism may provide alternative explanation for antibiotic resistance

Newly discovered molecular mechanism may provide alternative explanation for antibiotic resistance

The bacterium B. cereus had so far been considered to be exclusively endospore-forming. In response to harsh conditions, the bacteria form protective endospores enabling them to remain dormant for extended periods. When conditions are more favourable, the endospores reactivate to become fully functioning bacteria. [More]
Zurampic (lesinurad) approved to treat high levels of hyperuricemia associated with gout

Zurampic (lesinurad) approved to treat high levels of hyperuricemia associated with gout

The U.S. Food and Drug Administration today approved Zurampic (lesinurad) to treat high levels of uric acid in the blood (hyperuricemia) associated with gout, when used in combination with a xanthine oxidase inhibitor (XOI), a type of drug approved to reduce the production of uric acid in the body. [More]
FDA approves Uptravi tablets to treat adults with pulmonary arterial hypertension

FDA approves Uptravi tablets to treat adults with pulmonary arterial hypertension

On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation. [More]
Advertisement
Advertisement